Outcomes of Trastuzumab Therapy for 6 and 12 Months in Indonesian National Health Insurance System Clients with Operable HER2-Positive Breast Cancer Article Swipe
Wirsma Arif Harahap
,
Ramadhan
,
Daan Khambri
,
Samuel J Haryono
,
Ricvan Dana Nindrea
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.22034/apjcp.2017.18.4.1151
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.22034/apjcp.2017.18.4.1151
Objective: The aim of this study is to determine the outcome of trastuzumab therapy for 6 or 12 months in patients with HER2 positive operable breast cancer who followed the national health insurance system in Indonesia. Methods: Data were extracted from medical records of Dr. M Djamil General Hospital Padang and Dharmais Cancer Hospital/ National Cancer Center Jakarta for post-operative breast HER-2 positive cancer patients treated with trastuzumab for 6 or 12 months who had been followed up for at least 5 years (January 1st in 2010 until December 31st in 2015). Disease free survival and overall survival rates and their relationship with trastuzumab duration was investigated using survival analysis (the Kaplan-Meier method and log rank test). Data were analyzed using the STATA program. Results: A total of 121 women fulfilled the criteria of the study, 80 who had received trastuzumab for 6 months and 41 patients who received 12 months’ therapy. Disease free survival was 54 months (95% CI 45-63) compared with 63 months (95% CI 54-72), respectively. The log-rank test p value was 0.048 so the 12 months’ treatment regime did result in a significantly lower probability of recurrence compared with the 6 months’ regime (HR = 2.6). Analysis of the overall survival rate revealed median survival of 57 months (95% CI 49-64) for 6 months’ therapy compared to 62 months (95% CI 53-72) for 12 months. However, the log-rank test p value of 0.073 indicated that the extra six months of therapy did not decrease the probability of death (HR = 2.4). Conclusion: Trastuzumab therapy for 12 months reduced the recurrence rate in post-operative breast HER-2 positive cancer patients but did not significantly reduce mortality.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://pubmed.ncbi.nlm.nih.gov/28548467
- OA Status
- green
- Cited By
- 19
- References
- 10
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2616247321
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2616247321Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.22034/apjcp.2017.18.4.1151Digital Object Identifier
- Title
-
Outcomes of Trastuzumab Therapy for 6 and 12 Months in Indonesian National Health Insurance System Clients with Operable HER2-Positive Breast CancerWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-04-01Full publication date if available
- Authors
-
Wirsma Arif Harahap, Ramadhan, Daan Khambri, Samuel J Haryono, Ricvan Dana NindreaList of authors in order
- Landing page
-
https://pubmed.ncbi.nlm.nih.gov/28548467Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.22034/APJCP.2017.18.4.1151Direct OA link when available
- Concepts
-
Medicine, Trastuzumab, Breast cancer, Log-rank test, Internal medicine, Cancer, Survival analysis, Medical record, Gynecology, OncologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
19Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 4, 2021: 1, 2020: 3, 2019: 6, 2018: 3Per-year citation counts (last 5 years)
- References (count)
-
10Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2616247321 |
|---|---|
| doi | https://doi.org/10.22034/apjcp.2017.18.4.1151 |
| ids.mag | 2616247321 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/28548467 |
| ids.openalex | https://openalex.org/W2616247321 |
| fwci | 1.98271119 |
| type | article |
| title | Outcomes of Trastuzumab Therapy for 6 and 12 Months in Indonesian National Health Insurance System Clients with Operable HER2-Positive Breast Cancer |
| biblio.issue | 4 |
| biblio.volume | 18 |
| biblio.last_page | 1156 |
| biblio.first_page | 1151 |
| topics[0].id | https://openalex.org/T10755 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | HER2/EGFR in Cancer Research |
| topics[1].id | https://openalex.org/T10183 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9926000237464905 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1306 |
| topics[1].subfield.display_name | Cancer Research |
| topics[1].display_name | Breast Cancer Treatment Studies |
| topics[2].id | https://openalex.org/T11752 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9661999940872192 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Treatment and Pharmacology |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.90361088514328 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779786085 |
| concepts[1].level | 4 |
| concepts[1].score | 0.8628131151199341 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q412616 |
| concepts[1].display_name | Trastuzumab |
| concepts[2].id | https://openalex.org/C530470458 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6952219009399414 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[2].display_name | Breast cancer |
| concepts[3].id | https://openalex.org/C66339696 |
| concepts[3].level | 3 |
| concepts[3].score | 0.629291296005249 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q6089397 |
| concepts[3].display_name | Log-rank test |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.6267756223678589 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C121608353 |
| concepts[5].level | 2 |
| concepts[5].score | 0.48503655195236206 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[5].display_name | Cancer |
| concepts[6].id | https://openalex.org/C10515644 |
| concepts[6].level | 2 |
| concepts[6].score | 0.457535058259964 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q543310 |
| concepts[6].display_name | Survival analysis |
| concepts[7].id | https://openalex.org/C195910791 |
| concepts[7].level | 2 |
| concepts[7].score | 0.44244030117988586 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1324077 |
| concepts[7].display_name | Medical record |
| concepts[8].id | https://openalex.org/C29456083 |
| concepts[8].level | 1 |
| concepts[8].score | 0.421469509601593 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1221899 |
| concepts[8].display_name | Gynecology |
| concepts[9].id | https://openalex.org/C143998085 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3624923825263977 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[9].display_name | Oncology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.90361088514328 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/trastuzumab |
| keywords[1].score | 0.8628131151199341 |
| keywords[1].display_name | Trastuzumab |
| keywords[2].id | https://openalex.org/keywords/breast-cancer |
| keywords[2].score | 0.6952219009399414 |
| keywords[2].display_name | Breast cancer |
| keywords[3].id | https://openalex.org/keywords/log-rank-test |
| keywords[3].score | 0.629291296005249 |
| keywords[3].display_name | Log-rank test |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.6267756223678589 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/cancer |
| keywords[5].score | 0.48503655195236206 |
| keywords[5].display_name | Cancer |
| keywords[6].id | https://openalex.org/keywords/survival-analysis |
| keywords[6].score | 0.457535058259964 |
| keywords[6].display_name | Survival analysis |
| keywords[7].id | https://openalex.org/keywords/medical-record |
| keywords[7].score | 0.44244030117988586 |
| keywords[7].display_name | Medical record |
| keywords[8].id | https://openalex.org/keywords/gynecology |
| keywords[8].score | 0.421469509601593 |
| keywords[8].display_name | Gynecology |
| keywords[9].id | https://openalex.org/keywords/oncology |
| keywords[9].score | 0.3624923825263977 |
| keywords[9].display_name | Oncology |
| language | en |
| locations[0].id | pmid:28548467 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4306525036 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | PubMed |
| locations[0].source.host_organization | https://openalex.org/I1299303238 |
| locations[0].source.host_organization_name | National Institutes of Health |
| locations[0].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Asian Pacific journal of cancer prevention : APJCP |
| locations[0].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28548467 |
| locations[1].id | pmh:oai:europepmc.org:4465280 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306400806 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Europe PMC (PubMed Central) |
| locations[1].source.host_organization | https://openalex.org/I1303153112 |
| locations[1].source.host_organization_name | European Bioinformatics Institute |
| locations[1].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5494230 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:5494230 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://doi.org/10.22034/APJCP.2017.18.4.1151 |
| indexed_in | pubmed |
| authorships[0].author.id | https://openalex.org/A5034924695 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0356-5424 |
| authorships[0].author.display_name | Wirsma Arif Harahap |
| authorships[0].countries | ID |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I55892964 |
| authorships[0].affiliations[0].raw_affiliation_string | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[0].institutions[0].id | https://openalex.org/I55892964 |
| authorships[0].institutions[0].ror | https://ror.org/04ded0672 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I55892964 |
| authorships[0].institutions[0].country_code | ID |
| authorships[0].institutions[0].display_name | Andalas University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Arif Harahap W |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[1].author.id | https://openalex.org/A5066008026 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Ramadhan |
| authorships[1].countries | ID |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I55892964 |
| authorships[1].affiliations[0].raw_affiliation_string | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[1].institutions[0].id | https://openalex.org/I55892964 |
| authorships[1].institutions[0].ror | https://ror.org/04ded0672 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I55892964 |
| authorships[1].institutions[0].country_code | ID |
| authorships[1].institutions[0].display_name | Andalas University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ramadhan |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[2].author.id | https://openalex.org/A5030690370 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-4044-2554 |
| authorships[2].author.display_name | Daan Khambri |
| authorships[2].countries | ID |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I55892964 |
| authorships[2].affiliations[0].raw_affiliation_string | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[2].institutions[0].id | https://openalex.org/I55892964 |
| authorships[2].institutions[0].ror | https://ror.org/04ded0672 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I55892964 |
| authorships[2].institutions[0].country_code | ID |
| authorships[2].institutions[0].display_name | Andalas University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Khambri D |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[3].author.id | https://openalex.org/A5034155478 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6655-0633 |
| authorships[3].author.display_name | Samuel J Haryono |
| authorships[3].countries | ID |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I55892964 |
| authorships[3].affiliations[0].raw_affiliation_string | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[3].institutions[0].id | https://openalex.org/I55892964 |
| authorships[3].institutions[0].ror | https://ror.org/04ded0672 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I55892964 |
| authorships[3].institutions[0].country_code | ID |
| authorships[3].institutions[0].display_name | Andalas University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Haryono S |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[4].author.id | https://openalex.org/A5036520548 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1844-3323 |
| authorships[4].author.display_name | Ricvan Dana Nindrea |
| authorships[4].countries | ID |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I55892964 |
| authorships[4].affiliations[0].raw_affiliation_string | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| authorships[4].institutions[0].id | https://openalex.org/I55892964 |
| authorships[4].institutions[0].ror | https://ror.org/04ded0672 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I55892964 |
| authorships[4].institutions[0].country_code | ID |
| authorships[4].institutions[0].display_name | Andalas University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Dana Nindrea R |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Surgical Oncology Division Faculty of Medicine Universitas Andalas/ Dr. M Djamil General Hospital Padang, West Sumatera#N#Province, Indonesia. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.22034/APJCP.2017.18.4.1151 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2017-05-26T00:00:00 |
| display_name | Outcomes of Trastuzumab Therapy for 6 and 12 Months in Indonesian National Health Insurance System Clients with Operable HER2-Positive Breast Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10755 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | HER2/EGFR in Cancer Research |
| related_works | https://openalex.org/W2084938131, https://openalex.org/W3031505386, https://openalex.org/W2616247321, https://openalex.org/W1996291288, https://openalex.org/W2045298789, https://openalex.org/W2164790086, https://openalex.org/W3129708559, https://openalex.org/W2042730121, https://openalex.org/W2379597183, https://openalex.org/W1501040347 |
| cited_by_count | 19 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2021 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2020 |
| counts_by_year[2].cited_by_count | 3 |
| counts_by_year[3].year | 2019 |
| counts_by_year[3].cited_by_count | 6 |
| counts_by_year[4].year | 2018 |
| counts_by_year[4].cited_by_count | 3 |
| counts_by_year[5].year | 2017 |
| counts_by_year[5].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:5494230 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | http://doi.org/10.22034/APJCP.2017.18.4.1151 |
| primary_location.id | pmid:28548467 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4306525036 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | PubMed |
| primary_location.source.host_organization | https://openalex.org/I1299303238 |
| primary_location.source.host_organization_name | National Institutes of Health |
| primary_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Asian Pacific journal of cancer prevention : APJCP |
| primary_location.landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28548467 |
| publication_date | 2017-04-01 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2040935952, https://openalex.org/W1996778928, https://openalex.org/W2037013151, https://openalex.org/W2099067294, https://openalex.org/W2149908785, https://openalex.org/W2033732846, https://openalex.org/W2112979829, https://openalex.org/W1563649485, https://openalex.org/W2141393790, https://openalex.org/W2171277704 |
| referenced_works_count | 10 |
| abstract_inverted_index.5 | 81 |
| abstract_inverted_index.6 | 15, 69, 142, 194, 216 |
| abstract_inverted_index.= | 198, 253 |
| abstract_inverted_index.A | 125 |
| abstract_inverted_index.M | 45 |
| abstract_inverted_index.a | 185 |
| abstract_inverted_index.p | 172, 233 |
| abstract_inverted_index.12 | 17, 71, 149, 178, 227, 259 |
| abstract_inverted_index.41 | 145 |
| abstract_inverted_index.54 | 156 |
| abstract_inverted_index.57 | 210 |
| abstract_inverted_index.62 | 221 |
| abstract_inverted_index.63 | 163 |
| abstract_inverted_index.80 | 136 |
| abstract_inverted_index.CI | 159, 166, 213, 224 |
| abstract_inverted_index.at | 79 |
| abstract_inverted_index.in | 19, 34, 85, 90, 184, 265 |
| abstract_inverted_index.is | 6 |
| abstract_inverted_index.of | 3, 11, 43, 127, 133, 189, 201, 209, 235, 243, 250 |
| abstract_inverted_index.or | 16, 70 |
| abstract_inverted_index.so | 176 |
| abstract_inverted_index.to | 7, 220 |
| abstract_inverted_index.up | 77 |
| abstract_inverted_index.(HR | 197, 252 |
| abstract_inverted_index.121 | 128 |
| abstract_inverted_index.1st | 84 |
| abstract_inverted_index.Dr. | 44 |
| abstract_inverted_index.The | 1, 169 |
| abstract_inverted_index.aim | 2 |
| abstract_inverted_index.and | 50, 95, 99, 113, 144 |
| abstract_inverted_index.but | 272 |
| abstract_inverted_index.did | 182, 245, 273 |
| abstract_inverted_index.for | 14, 58, 68, 78, 141, 215, 226, 258 |
| abstract_inverted_index.had | 74, 138 |
| abstract_inverted_index.log | 114 |
| abstract_inverted_index.not | 246, 274 |
| abstract_inverted_index.six | 241 |
| abstract_inverted_index.the | 9, 29, 121, 131, 134, 177, 193, 202, 230, 239, 248, 262 |
| abstract_inverted_index.was | 105, 155, 174 |
| abstract_inverted_index.who | 27, 73, 137, 147 |
| abstract_inverted_index.(95% | 158, 165, 212, 223 |
| abstract_inverted_index.(the | 110 |
| abstract_inverted_index.2010 | 86 |
| abstract_inverted_index.31st | 89 |
| abstract_inverted_index.Data | 37, 117 |
| abstract_inverted_index.HER2 | 22 |
| abstract_inverted_index.been | 75 |
| abstract_inverted_index.free | 93, 153 |
| abstract_inverted_index.from | 40 |
| abstract_inverted_index.rank | 115 |
| abstract_inverted_index.rate | 205, 264 |
| abstract_inverted_index.test | 171, 232 |
| abstract_inverted_index.that | 238 |
| abstract_inverted_index.this | 4 |
| abstract_inverted_index.were | 38, 118 |
| abstract_inverted_index.with | 21, 66, 102, 162, 192 |
| abstract_inverted_index.0.048 | 175 |
| abstract_inverted_index.0.073 | 236 |
| abstract_inverted_index.2.4). | 254 |
| abstract_inverted_index.2.6). | 199 |
| abstract_inverted_index.HER-2 | 61, 268 |
| abstract_inverted_index.STATA | 122 |
| abstract_inverted_index.death | 251 |
| abstract_inverted_index.extra | 240 |
| abstract_inverted_index.least | 80 |
| abstract_inverted_index.lower | 187 |
| abstract_inverted_index.rates | 98 |
| abstract_inverted_index.study | 5 |
| abstract_inverted_index.their | 100 |
| abstract_inverted_index.total | 126 |
| abstract_inverted_index.until | 87 |
| abstract_inverted_index.using | 107, 120 |
| abstract_inverted_index.value | 173, 234 |
| abstract_inverted_index.women | 129 |
| abstract_inverted_index.years | 82 |
| abstract_inverted_index.2015). | 91 |
| abstract_inverted_index.45-63) | 160 |
| abstract_inverted_index.49-64) | 214 |
| abstract_inverted_index.53-72) | 225 |
| abstract_inverted_index.Cancer | 52, 55 |
| abstract_inverted_index.Center | 56 |
| abstract_inverted_index.Djamil | 46 |
| abstract_inverted_index.Padang | 49 |
| abstract_inverted_index.breast | 25, 60, 267 |
| abstract_inverted_index.cancer | 26, 63, 270 |
| abstract_inverted_index.health | 31 |
| abstract_inverted_index.median | 207 |
| abstract_inverted_index.method | 112 |
| abstract_inverted_index.months | 18, 72, 143, 157, 164, 211, 222, 242, 260 |
| abstract_inverted_index.reduce | 276 |
| abstract_inverted_index.regime | 181, 196 |
| abstract_inverted_index.result | 183 |
| abstract_inverted_index.study, | 135 |
| abstract_inverted_index.system | 33 |
| abstract_inverted_index.test). | 116 |
| abstract_inverted_index.54-72), | 167 |
| abstract_inverted_index.Disease | 92, 152 |
| abstract_inverted_index.General | 47 |
| abstract_inverted_index.Jakarta | 57 |
| abstract_inverted_index.medical | 41 |
| abstract_inverted_index.months. | 228 |
| abstract_inverted_index.outcome | 10 |
| abstract_inverted_index.overall | 96, 203 |
| abstract_inverted_index.records | 42 |
| abstract_inverted_index.reduced | 261 |
| abstract_inverted_index.therapy | 13, 218, 244, 257 |
| abstract_inverted_index.treated | 65 |
| abstract_inverted_index.(January | 83 |
| abstract_inverted_index.Analysis | 200 |
| abstract_inverted_index.December | 88 |
| abstract_inverted_index.Dharmais | 51 |
| abstract_inverted_index.Hospital | 48 |
| abstract_inverted_index.However, | 229 |
| abstract_inverted_index.Methods: | 36 |
| abstract_inverted_index.National | 54 |
| abstract_inverted_index.Results: | 124 |
| abstract_inverted_index.analysis | 109 |
| abstract_inverted_index.analyzed | 119 |
| abstract_inverted_index.compared | 161, 191, 219 |
| abstract_inverted_index.criteria | 132 |
| abstract_inverted_index.decrease | 247 |
| abstract_inverted_index.duration | 104 |
| abstract_inverted_index.followed | 28, 76 |
| abstract_inverted_index.log-rank | 170, 231 |
| abstract_inverted_index.national | 30 |
| abstract_inverted_index.operable | 24 |
| abstract_inverted_index.patients | 20, 64, 146, 271 |
| abstract_inverted_index.positive | 23, 62, 269 |
| abstract_inverted_index.program. | 123 |
| abstract_inverted_index.received | 139, 148 |
| abstract_inverted_index.revealed | 206 |
| abstract_inverted_index.survival | 94, 97, 108, 154, 204, 208 |
| abstract_inverted_index.therapy. | 151 |
| abstract_inverted_index.Hospital/ | 53 |
| abstract_inverted_index.determine | 8 |
| abstract_inverted_index.extracted | 39 |
| abstract_inverted_index.fulfilled | 130 |
| abstract_inverted_index.indicated | 237 |
| abstract_inverted_index.insurance | 32 |
| abstract_inverted_index.months’ | 150, 179, 195, 217 |
| abstract_inverted_index.treatment | 180 |
| abstract_inverted_index.Indonesia. | 35 |
| abstract_inverted_index.Objective: | 0 |
| abstract_inverted_index.mortality. | 277 |
| abstract_inverted_index.recurrence | 190, 263 |
| abstract_inverted_index.Conclusion: | 255 |
| abstract_inverted_index.Trastuzumab | 256 |
| abstract_inverted_index.probability | 188, 249 |
| abstract_inverted_index.trastuzumab | 12, 67, 103, 140 |
| abstract_inverted_index.Kaplan-Meier | 111 |
| abstract_inverted_index.investigated | 106 |
| abstract_inverted_index.relationship | 101 |
| abstract_inverted_index.respectively. | 168 |
| abstract_inverted_index.significantly | 186, 275 |
| abstract_inverted_index.post-operative | 59, 266 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7099999785423279 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.85144117 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |